RGC
NBIX icon

Roberts, Glore & Co’s Neurocrine Biosciences NBIX Stock Holding History

Roberts, Glore & Co’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,492
Closed -$204K – 209
2024
Q4 		$204K Buy
+1,492
New +$204K 0.06% 203
2024
Q3 		– Sell
-1,492
Closed -$205K – 212
2024
Q2 		$205K Hold
1,492
– – 0.06% 197
2024
Q1 		$206K Buy
+1,492
New +$206K 0.06% 201